Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma

被引:5
作者
Hou, Fang [1 ]
Huang, Qi-Ming [1 ]
Hu, Dan-Ning [2 ,3 ]
Jonas, Jost B. [1 ,4 ]
Wei, Wen-Bin [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr, 1 Dong Jiao Min Xiang, Beijing 100730, Peoples R China
[2] New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, 310 E 14th St, New York, NY 10003 USA
[3] New York Eye & Ear Infirm Mt Sinai, Dept Pathol, 310 E 14th St, New York, NY 10003 USA
[4] Ruprecht Karls Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-67117 Heidelberg, Germany
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
uveal melanoma; dendritic cells; immune escape; gene expression profile; SLAMF7; DENDRITIC CELLS; MULTIPLE-MYELOMA; DOWN-REGULATION; CANCER-CELLS; AQUAPORIN; 9; T-CELLS; EXPRESSION; TUMOR; INFILTRATION; INFLAMMATION;
D O I
10.18240/ijo.2016.12.01
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To examine the genetic profile of primary uveal melanoma (UM) as compared to UM in immune escape. METHODS: Dendritic cells (DC) loaded with lysates of UM cells of high metastatic potential were used to stimulate cytotoxic T-lymphocytes (CTLs). When CTLs co-cultured with the UM cells, most UM cells could be eliminated. Survival UM cells grew slowly and were considered to be survival variants and examined by a microarray analysis. These differential genes were analyzed further with Venn Diagrams and functions related to immune escape. We additionally examined transcriptional changes of manually selected survival variants of UM cells and of clinical UM samples by quantitativereal-timepolymerasechainreaction(qRT-PCR), and analyzed the correlation of these expressions and patients' survival. RESULTS: Gene expression analyses revealed a marked up -regulation of SLAMF7 and CCL22 and a significant down -regulation of KRT10 and FXYD3 and ABCC2. The expression of these genes in the relapsed UM was significantly greater than those in primary UM. UM patients with overexpression of these genes had a shorter survival period as compared with those of their underexpression. CONCLUSION: Gene expression, in particular of SLAMF7, CCL22, KRT10, FXYD3 and ABCC2 differed between primary UM cells and survival variants of UM cells.
引用
收藏
页码:1701 / 1712
页数:12
相关论文
共 49 条
  • [1] Alaniz L, 2014, METHODS MOL BIOL, V1139, P27, DOI 10.1007/978-1-4939-0345-0_3
  • [2] Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
    Balasa, Balaji
    Yun, Rui
    Belmar, Nicole A.
    Fox, Melvin
    Chao, Debra T.
    Robbins, Michael D.
    Starling, Gary C.
    Rice, Audie G.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (01) : 61 - 73
  • [3] Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape
    Bernal, Monica
    Garcia-Alcalde, Fernando
    Concha, Angel
    Cano, Carlos
    Blanco, Armando
    Garrido, Federico
    Ruiz-Cabello, Francisco
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (06) : 803 - 816
  • [4] A Link between FXYD3 (Mat-8)-mediated Na,K-ATPase Regulation and Differentiation of Caco-2 Intestinal Epithelial Cells
    Bibert, Stephanie
    Aebischer, David
    Desgranges, Florian
    Roy, Sophie
    Schaer, Daniele
    Kharoubi-Hess, Solange
    Horisberger, Jean-Daniel
    Geering, Kaethi
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2009, 20 (04) : 1132 - 1140
  • [5] Inflammation in uveal melanoma
    Bronkhorst, I. H. G.
    Jager, M. J.
    [J]. EYE, 2013, 27 (02) : 217 - 223
  • [6] Uveal Melanoma: The Inflammatory Microenvironment
    Bronkhorst, Inge H. G.
    Jager, Martine J.
    [J]. JOURNAL OF INNATE IMMUNITY, 2012, 4 (5-6) : 454 - 462
  • [7] Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
    Buder, Kristina
    Gesierich, Anja
    Gelbrich, Goetz
    Goebeler, Matthias
    [J]. CANCER MEDICINE, 2013, 2 (05): : 674 - 686
  • [8] Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma
    Chen, Kevin G.
    Valencia, Julio C.
    Gillet, Jean-Pierre
    Hearing, Vincent J.
    Gottesman, Michael M.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2009, 22 (06) : 740 - 749
  • [9] Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
    Collins, Shauna M.
    Bakan, Courtney E.
    Swartzel, Gina D.
    Hofmeister, Craig C.
    Efebera, Yvonne A.
    Kwon, Hakju
    Starling, Gary C.
    Ciarlariello, David
    Bhaskar, Shakthi
    Briercheck, Edward L.
    Hughes, Tiffany
    Yu, Jianhua
    Rice, Audie
    Benson, Don M., Jr.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (12) : 1841 - 1849
  • [10] Dadlchah E, 2013, ARCH IRAN MED, V16, P463, DOI 013168/AIm.006